A Day Up For GH Research PLC
Tue, Nov 22, 2022 at 07:25 PM

GH Research PLC (GHRS:NASDAQ) jumped higher at $12.51, representing a gain of 25.9%. On Tue, Nov 22, 2022, GHRS:NASDAQ hit a New 2-Week High of $12.51. The stock got featured on our News Catalysts scanner on Thu, Nov 10, 2022 at 07:54 AM in the 'INVESTOR UPDATE' category. From Wed, Nov 09, 2022, the stock recorded 55.56% Up Days and 70.00% Green Days
About GH Research PLC (GHRS:NASDAQ)
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
Top 10 Gainers:
- Palisade Bio Inc. (PALI:NASDAQ), 81.08%
- Motorsport Games Inc. (MSGM:NASDAQ), 51.11%
- FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 47.57%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 34.31%
- XL Group Ltd (XL:NYSE), 30.91%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 30%
- Digital Brands Group Inc. (DBGI:NASDAQ), 28.53%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Draganfly Inc. (DPRO:NASDAQ), 27.19%
- GH Research PLC (GHRS:NASDAQ), 25.86%